PLAZZI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 37.675
AS - Asia 21.075
EU - Europa 11.918
SA - Sud America 2.938
AF - Africa 418
OC - Oceania 146
Continente sconosciuto - Info sul continente non disponibili 22
Totale 74.192
Nazione #
US - Stati Uniti d'America 36.975
SG - Singapore 8.569
HK - Hong Kong 4.021
CN - Cina 2.904
IT - Italia 2.813
GB - Regno Unito 2.617
VN - Vietnam 2.386
BR - Brasile 2.327
FI - Finlandia 1.377
BD - Bangladesh 848
SE - Svezia 846
FR - Francia 767
RU - Federazione Russa 767
DE - Germania 655
BG - Bulgaria 505
IN - India 420
CA - Canada 408
KR - Corea 354
ID - Indonesia 290
AT - Austria 243
NL - Olanda 243
AR - Argentina 221
ES - Italia 201
JP - Giappone 188
CZ - Repubblica Ceca 157
MX - Messico 155
IQ - Iraq 142
AU - Australia 130
TR - Turchia 125
UA - Ucraina 115
PK - Pakistan 112
AE - Emirati Arabi Uniti 102
DK - Danimarca 97
ZA - Sudafrica 96
EC - Ecuador 89
MY - Malesia 82
PL - Polonia 81
IE - Irlanda 79
PH - Filippine 71
CL - Cile 70
EG - Egitto 66
CO - Colombia 64
VE - Venezuela 63
UZ - Uzbekistan 57
CH - Svizzera 54
MA - Marocco 54
BE - Belgio 48
IR - Iran 44
SA - Arabia Saudita 41
KE - Kenya 38
JO - Giordania 37
TN - Tunisia 36
LT - Lituania 35
NP - Nepal 35
PE - Perù 32
RO - Romania 32
DZ - Algeria 30
JM - Giamaica 29
AZ - Azerbaigian 28
TW - Taiwan 28
HU - Ungheria 27
PY - Paraguay 26
CR - Costa Rica 24
PT - Portogallo 24
BO - Bolivia 23
ET - Etiopia 23
TH - Thailandia 23
KZ - Kazakistan 22
IL - Israele 21
UY - Uruguay 21
GR - Grecia 20
HN - Honduras 17
RS - Serbia 16
AL - Albania 15
NZ - Nuova Zelanda 15
BY - Bielorussia 14
PS - Palestinian Territory 14
DO - Repubblica Dominicana 12
EE - Estonia 12
NO - Norvegia 12
QA - Qatar 12
BH - Bahrain 11
KH - Cambogia 10
LB - Libano 10
XK - ???statistics.table.value.countryCode.XK??? 10
GE - Georgia 9
GT - Guatemala 9
KW - Kuwait 9
NG - Nigeria 9
OM - Oman 9
SN - Senegal 9
BB - Barbados 8
LU - Lussemburgo 8
NI - Nicaragua 8
BW - Botswana 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
TT - Trinidad e Tobago 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AM - Armenia 6
Totale 74.051
Città #
Singapore 6.754
Santa Clara 4.217
Hong Kong 3.958
Fairfield 3.895
Ashburn 3.791
San Jose 1.874
Chandler 1.669
Woodbridge 1.605
Houston 1.489
Wilmington 1.376
Seattle 1.365
London 1.358
Helsinki 1.309
Cambridge 1.282
Council Bluffs 870
The Dalles 760
Ho Chi Minh City 749
Los Angeles 653
Ann Arbor 637
San Diego 606
Hanoi 601
Nyköping 598
Princeton 588
Beijing 583
Dallas 562
New York 528
Southend 495
Sofia 493
Chicago 482
Hefei 443
Milan 411
Lauterbourg 406
Moscow 387
Seoul 315
Des Moines 308
Modena 308
Buffalo 294
Jakarta 217
São Paulo 217
Redondo Beach 173
Rome 172
Shanghai 169
Vienna 168
Salt Lake City 166
Da Nang 150
Brno 134
Toronto 121
Bologna 120
Tokyo 120
Munich 107
Boardman 103
Nuremberg 100
Haiphong 94
Jacksonville 94
Miano 88
Orem 88
Phoenix 88
Naples 85
Frankfurt am Main 83
Dublin 80
Columbus 79
Norwalk 79
Paris 79
Atlanta 78
Elk Grove Village 76
Tampa 76
San Francisco 75
Brooklyn 73
Rio de Janeiro 69
Belo Horizonte 65
Montreal 65
Amsterdam 62
Warsaw 62
Kilburn 61
Redwood City 55
Copenhagen 52
Melbourne 51
Tashkent 51
Dearborn 50
Denver 50
Galveston 50
Guangzhou 50
Baghdad 49
Boston 49
Chiswick 49
Falls Church 49
Hounslow 49
Sterling 48
Vancouver 48
Chennai 47
Miami 47
Dhaka 46
Mexico City 45
Santiago 45
Cairo 43
Biên Hòa 42
Charlotte 42
Hải Dương 42
Florence 41
Palermo 39
Totale 53.184
Nome #
Narcolepsy 417
National Sleep Foundation's sleep quality recommendations: first report 413
Maladaptive Daydreaming in an Adult Italian Population During the COVID-19 Lockdown 395
The Brain Correlates of Laugh and Cataplexy in Childhood Narcolepsy 360
Childhood trauma, reflective functioning, and problematic mobile phone use among male and female adolescents 328
Bilateral centrotemporal spikes triggered by blinking: an unusual form of sensory input with related cortical EEG activity 319
The neuronal network of laughing in young patients with untreated narcolepsy 318
Propriospinal myoclonus at the sleep-wake transition: a new type of parasomnia 292
Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans 286
Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1 280
Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts 279
Narcolepsy treatment: pharmacological and behavioral strategies in adults and children 278
Sleep disturbances and sleep disorders as risk factors for chronic postsurgical pain: A systematic review and meta-analysis 276
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome 273
REM sleep behaviour disorder 271
Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health 266
European guideline and expert statements on the management of narcolepsy in adults and children 255
The Distinguishing Motor Features of Cataplexy: A Study from Video Recorded Attacks 249
Mitochondrial neurogastrointestinal encephalomyopathy: Evidence of mitochondrial DNA depletion in the small intestine 249
(Not so) Smart sleep tracking through the phone: Findings from a polysomnography study testing the reliability of four sleep applications 248
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep 247
Psychometric properties of the Sleep Hygiene Index in a large Italian community sample 246
A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy 245
The Interplay Between Problematic Online Pornography Use, Psychological Stress, Emotion Dysregulation and Insomnia Symptoms During the COVID-19 Pandemic: A Mediation Analysis 244
Motor pattern of periodic limb movements during sleep 237
International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders 236
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial 227
Insomnia in primary care: a survey conducted on Italian patients older than 50 years—results from the “Sonno e Salute” study 226
In-field assessment of sodium oxybate effect in pediatric type 1 narcolepsy: An actigraphic study 224
Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome 224
The spectrum of REM sleep-related episodes in children with type 1 narcolepsy 222
A quantitative statistical analysis of the submentalis muscle EMG amplitude during sleep in normal controls and patients with REM sleep behavior disorder 222
Can smartphone sleep applications reliably assess sleep-wake cycle? Preliminary findings from a PSG study 221
Narcolepsy is strongly associated with the T-cell receptor alpha locus 221
Red Flags for early referral of people with symptoms suggestive of narcolepsy: a report from a national multidisciplinary panel 220
Narcolepsy is a paediatric disease: Use red flags to recognise it 220
A randomized study of solriamfetol for excessive sleepiness in narcolepsy 220
Sleep-related hypermotor epilepsy (SHE): Contribution of known genes in 103 patients 215
HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency 214
A quantitative analysis of the submentalis muscle electromyographic amplitude during rapid eye movement sleep across the lifespan 214
Motor pattern of periodic limb movements in sleep in idiopathic RLS patients 212
A preliminary quantitative analysis of REM sleep chin EMG in Parkinson's disease with or without REM sleep behavior disorder 211
Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy 211
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment 211
The burden of narcolepsy with cataplexy: How disease history and clinical features influence socio-economic outcomes 210
Cortical and Subcortical Brain Changes in Children and Adolescents With Narcolepsy Type 1 209
Diagnostic accuracy of a structured interview for nocturnal frontal lobe epilepsy (SINFLE): a proposal for developing diagnostic criteria 208
Beyond the neuropsychology of dreaming: Insights into the neural basis of dreaming with new techniques of sleep recording and analysis 207
Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders 204
Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study 203
Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies 202
Searching for novel candidate biomarkers of rls in blood by proteomic analysis 202
High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy 200
Polysomnographic study of sleeplessness and oneiricisms in the alcohol withdrawal syndrome 199
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder 198
A standardized test to document cataplexy 196
A case of REM sleep behavior disorder, narcolepsy-cataplexy, parkinsonism and rheumatoid arthritis 196
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder 196
Narcolepsy with cataplexy mimicry: the strange case of two sisters 195
Neuronal surface antibodies are common in children with narcolepsy and active movement disorders 195
Association of restless legs syndrome with nocturnal eating: a case-control study 194
Actigraphic assessment of sleep/wake behavior in central disorders of hypersomnolence 194
Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci 194
Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study 194
Incidence of sudden unexpected death in nocturnal frontal lobe epilepsy: a cohort study 192
Autonomic disturbances in narcolepsy 191
Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy 189
Co-occurrence of anxiety and depressive symptoms, suicidal thoughts, and hopelessness in patients with narcolepsy type 1 188
Are sleep disturbances a risk factor for suicidal behavior in the first episode of psychosis? Evidence from a systematic review 187
Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency 186
Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy 186
ABNORMAL LACTATE AFTER EFFORT IN HEALTHY CARRIERS OF LEBERS HEREDITARY OPTIC NEUROPATHY 185
A provisional tool for the measurement of sleep satisfaction 185
The clinical spectrum of childhood narcolepsy 185
Modulation of the muscle activity during sleep in cervical dystonia 185
Sleep-related stridor due to dystonic vocal cord motion and neurogenic tachypnea/tachycardia in multiple system atrophy 184
Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility 184
A pragmatic approach to test the reliability of a classification of permanent impairment due to narcolepsy 184
INTRAVENOUS HIGH-DOSE IMMUNOGLOBULIN TREATMENT IN RECENT ONSET CHILDHOOD NARCOLEPSY WITH CATAPLEXY 183
Age-related differences in sleep-dependent consolidation of motor skills in patients with narcolepsy type 1 182
Complex movement disorders at disease onset in childhood narcolepsy with cataplexy 181
Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort 180
Impact of acute administration of sodium oxybate on heart rate variability in children with type 1 narcolepsy 180
Parental quality of life and involvement in intervention for children or adolescents with autism spectrum disorders: A systematic review 180
Sexsomnia: a diagnostic challenge, a case report 179
Narcolepsy features in young patients 179
Impaired cortical and autonomic arousal during sleep in multiple system atrophy 178
Body mass index-independent metabolic alterations in narcolepsy with cataplexy 178
Cardiovascular autonomic dysfunctions and sleep disorders 178
Exploring Addictive Online Behaviors in Patients with Narcolepsy Type 1 177
Family recurrence and oligo-anuria predict uremic restless legs syndrome 177
Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases 177
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies 177
Group I nonreciprocal inhibition in restless legs syndrome secondary to chronic renal failure 176
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy 175
Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study 175
Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study 175
Common variants in P2RY11 are associated with narcolepsy 174
Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients 172
Creativity in narcolepsy type 1: The role of dissociated rem sleep manifestations 172
Totale 21.954
Categoria #
all - tutte 401.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 401.959


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 0 0 0 0 0 0 0 0 355
2021/20227.719 258 1.233 869 232 241 315 457 368 1.045 699 1.172 830
2022/20235.947 934 354 378 384 626 1.021 92 600 818 106 325 309
2023/20244.326 182 275 205 336 896 127 232 854 174 108 141 796
2024/202514.866 574 143 81 1.117 2.583 2.243 1.108 715 1.903 1.385 1.254 1.760
2025/202631.638 1.301 906 2.512 3.026 4.608 1.899 5.156 1.730 3.323 2.485 2.435 2.257
Totale 74.853